The induction of chromosome aberrations by restriction endonucleases that produce blunt-end or cohesive-end double-strand breaks.

Abstract

Restriction endonucleases have been used to study the involvement of specific types of DNA damages in the production of chromosome aberrations. In this study restriction endonucleases were introduced into viable CHO cells using osmolytic shock of pinocytic vesicles. We compared two cohesive-end cutters, Msp I (CCGG-2-base overlap) and Sau3A I (GATC-4-base overlap) with two blunt-end cutters, Alu I (AGCT) and Rsa I (GTAC). All 4 enzymes were effective at inducing aberrations. The 4-base overlap cohesive-end cutter Sau3A I was approximately as effective as the blunt-end cutter Alu I. We present evidence that cutting frequency rather than cut end-structure is important in determining efficiency of aberration induction. There is over-dispersion of the distribution of dicentrics and rings among cells, and the data could be fitted to a Neyman Type A distribution, a modified Poisson, that indicates that there is a probability distribution both for the entry of the enzyme into a cell nucleus and for the induction of aberrations once the enzyme has entered a cell nucleus. In addition, we used Alu I to determine the sensitivity of cells to aberration induction in the different stages of the cell cycle. Alu I induced aberrations in all stages of the cycle, chromatid-type in S/G2 and chromosome-type in G1. In agreement with data of others, there were variations in sensitivity with cycle stage, and changes in the proportions of the different aberration classes for chromatid-type aberrations.

• Authors: R A Winegar, R J Preston
• Journal: Mutation research (Mutat Res) Vol. 197 Issue 1 Pg. 141-9 (Jan 1988) ISSN: 0027-5107 [Print] Netherlands
• PMID: 2827018 (Publication Type: Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.)

Chemical References

• DNA Restriction Enzymes

Topics

• Animals
• Cell Cycle
• Cell Line
• Chromatids (drug effects)
• Chromosome Aberrations
• DNA Restriction Enzymes (pharmacology)
• Dose-Response Relationship, Drug
• Kinetics